Literature DB >> 9146947

Improved dextran preparation of human leucocytes for chemiluminescence analysis of the oxidative burst of polymorphonuclear cells.

M Cíz1, A Lojek.   

Abstract

An improved method for the preparation of leucocyte-rich plasma from human blood samples for chemiluminescence (CL) analysis is described. Heparinized blood is layered over 4% dextran in a ratio of 1:1 (v/v). The leucocyte-rich plasma is obtained after a 1 h sedimentation of the erythrocytes. When compared with the plasma obtained by the usual method of mixing blood with dextran, the residual red cell count was reduced. On the other hand, the index of phagocytosis (peak values of activated phagocytosis/spontaneous phagocytosis) was increased. This is caused by increased spontaneous CL activity after mixing blood with dextran, which can activate leucocytes. Such activation was observed both in plasma samples and in whole blood samples when measured immediately after dextran addition or after 1 h incubation with dextran.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146947     DOI: 10.1046/j.1365-2257.1997.00211.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

1.  The effect of hyaluronan combined with KI3 complex (Hyiodine wound dressing) on keratinocytes and immune cells.

Authors:  Jana Frankova; Lukas Kubala; Vladimir Velebny; Milan Ciz; Antonin Lojek
Journal:  J Mater Sci Mater Med       Date:  2006-10       Impact factor: 3.896

2.  Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay.

Authors:  Marília P P Kanegae; Valdecir F Ximenes; Roberto P Falcão; Virgílio A R Colturato; Ederson R de Mattos; Iguatemy L Brunetti; Luiz Marcos da Fonseca
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Silkworm (Bombyx mori) hemocytes do not produce reactive oxygen metabolites as a part of defense mechanisms.

Authors:  P Hyrsl; M Cíz; L Kubala; A Lojek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.